For more than two out of three unemployed workers, jobless benefits exceed their old pay, researchers say. That can raise awkward questions for workers, bosses and policymakers.
(Image credit: Mark Felix/AFP/AFP via Getty Images)
Traders are wearing masks and must undergo a health screening before entering the New York Stock Exchange, which shifted to electronic trading in March because of COVID-19.
(Image credit: Brendan McDermid/Reuters)
Evidence points to wildlife as the starting point. But it could take years to pinpoint the source.
(Image credit: NPR/YouTube)
In recent years, Congress has approved laws formalizing the transition process and ensuring there is buy-in from the two major candidates, even at this stage of the campaign.
(Image credit: Patrick Semansky/AP)
Most places where Americans usually register to vote have been closed since March. It's led to a big drop in new registrations right before an election that was expected to see record turnout.
(Image credit: Dominick Reuter/AFP via Getty Images)
Prisoners and their relatives have contradicted state officials about the conditions and medical care inside Indiana prisons. Some say didn't learn an imprisoned relative had COVID-19 until he died.
(Image credit: Annacaroline Caruso/ WVPE)
With state income and sales tax revenues crashing, one expert predicts, "We're about to see a school funding crisis unlike anything we have ever seen in modern history."
(Image credit: LA Johnson/NPR)
The new guidelines stipulate religious centers must limit attendance to 100 persons or 25% of the building's capacity, whichever is lower. They also recommend against singing and group recitation.
(Image credit: Eric Risberg/AP)
Sweden's controversial strategy has become a rallying cry of anti-lockdown protesters in the U.S. But not even the official behind the country's coronavirus approach is sure it was the right call.
(Image credit: Jonathan Nackstrand/AFP via Getty Images)
The WHO cited a scientific study published last week suggesting that proposed COVID-19 drug hydroxychloroqine may do more harm than good in halting its study to review data.
(Image credit: George Frey/AFP via Getty Images)